Topic: AMP v Myriad

Inevitable? Supreme Court Myriad Ruling Leads to Challenge of Human Stem Cell Patent

When the Supreme Court ruled last month that human genes were not patent eligible, writes attorney Antoinette Konski of Foley & Lardner: “[m]any in the biotech community were relieved that the Supreme Court in Myriad limited its holding of patent-ineligibility to isolated, naturally-occurring genes. However, patent practitioners cautioned that Myriad’s holding could potentially be applied… Read more »

Attorney: Myriad Decision Shows SCOTUS Striking Necessary Patent Law Balance

“You know you’re living in the end of days when both the ACLU and the Wall Street Journal praise the same Supreme Court decision…” – Gideon Schor Here’s an interesting perspective on yesterday’s Supreme Court decision in AMP v. Myriad from Gideon Schor, litigation partner at Wilson Sonsini Goodrich & Rosati [bold ours]: “…The Court… Read more »